Physician

Claude William Gilbreath, M.D.

According to 2025 Medicare claims, Claude Gilbreath, M.D. (NPI: 1356324594) practices family practice in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is FAMILY MEDICINE PHYSICIANS, L.L.C. (NPI: 1962428953; TIN: 47-0920977) and primary practice location at 70403-1478. Gilbreath is affiliated with the Dependable Care Partners, Select (ACO ID: A5666), participating under the MSSP model.

Gilbreath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 2,543 HCPCS/CPT codes, and received $109,946 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 13,636 prescription claims across 906 beneficiaries totaling $1,152,981 in drug costs, led by Ozempic (Semaglutide). DME data shows 108 claims. Open Payments data shows 95 records totaling $1,646. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $33,580 to $9,768.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	562	2,949	$103,397
2016	668	2,875	$149,861
2017	813	3,758	$189,579
2018	794	4,036	$199,238
2019	796	3,938	$191,827
2020	639	3,221	$144,255
2021	484	2,607	$123,393
2022	449	1,739	$85,022
2023	492	2,270	$110,385
2024	503	2,543	$109,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	784	17,726	$900,715
2016	784	17,047	$871,706
2017	829	17,244	$905,882
2018	838	17,469	$899,825
2019	864	15,794	$830,644
2020	947	15,793	$944,289
2021	935	15,851	$1,044,349
2022	889	14,291	$1,060,825
2023	920	13,956	$1,097,139
2024	906	13,636	$1,152,981

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	143	581	$24,559
2016	113	597	$13,979
2017	50	257	$7,550
2018	65	213	$4,412
2019	46	262	$4,614
2020	66	251	$7,706
2021	69	317	$10,851
2022	66	276	$10,285
2023	40	263	$11,641
2024	36	108	$2,812

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	307	307	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	386	$82
99497	Advance care planning, first 30 minutes	58	58	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	234	407	$62
J1100	Injection, dexamethasone sodium phosphate, 1 mg	98	888	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	160	6,664	$218,413
Mounjaro	Tirzepatide	130	5,208	$194,885
Jardiance	Empagliflozin	124	5,700	$106,025
Eliquis	Apixaban	114	4,830	$86,926
Prolia	Denosumab	27	4,860	$46,792

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	N/R	17	$1,343
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	26	$719
A7035	Headgear used with positive airway pressure device	N	14	17	$281
A7037	Tubing used with positive airway pressure device	N	N/R	16	$164
A7038	Filter, disposable, used with positive airway pressure device	N	11	20	$153

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$1,646	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Claude William Gilbreath, M.D.?

Tedicare shows public-source Medicare data for Claude William Gilbreath, M.D. (NPI 1356324594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Claude William Gilbreath, M.D. have ACO affiliation data?

Claude William Gilbreath, M.D. is shown with ACO affiliation data for Dependable Care Partners, Select (MSSP, ACO ID A5666).

What billing organization is linked to Claude William Gilbreath, M.D.?

Claude William Gilbreath, M.D. is linked to FAMILY MEDICINE PHYSICIANS, L.L.C. (billing NPI 1962428953) in the available physician profile data.

Does Claude William Gilbreath, M.D. have Open Payments data?

Claude William Gilbreath, M.D. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.